Research output

1. THE ANALYSIS OF PRESCRIBING CDK4/6 INHIBITORS FOR PATIENTS WITH BREAST CANCER IN REAL CLINICAL PRACTICE

   Research output: Contribution to conference › Abstract › peer-review

2. Russian multicenter experience of using talazoparib in the treatment of patients with brca-associated metastatic breast cancer

   Research output: Contribution to journal › Article › peer-review

3. Ингибиторы циклинзависимых киназ - новый класс препаратов в онкологии. Достижения и перспективы развития при лечении эр+ / her 2- рака молочной железы

   Research output: Contribution to journal › Article › peer-review

View all (3) »